Akerna Corp KERN shares are buying and selling larger by 18.6% to $0.37 throughout Monday’s session amid continued momentum in hashish shares on U.S. efforts to reschedule marijuana.
Hashish shares have risen over the previous week on information that the Division of Well being and Human Providers (HHS) proposed reclassifying marijuana to a lower-risk drug class.
EXCLUSIVE: Hashish Tipping Level, Verano CEO Weighs In On HHS Rescheduling Proposal
In accordance with a letter dated August 29 seen by Bloomberg Information, a high-ranking official from the Division of Well being and Human Providers has written to DEA Administrator Anne Milgram, urging the reclassification of marijuana from Schedule I to Schedule III underneath the Managed Substances Act.
This shift displays a big change, as Schedule I substances embody extremely abused medication like heroin.
The advice is knowledgeable by an FDA analysis of marijuana’s classification. The Managed Substances Act categorizes substances based mostly on medical utilization, abuse potential and security.
These shifting circumstances dealing with the hashish trade will likely be mentioned on the Benzinga Hashish Capital Convention so you will not need to miss out. Be a part of us in Chicago this September 27-28.
Get your tickets at this time earlier than costs improve and safe a spot on the epicenter of hashish funding and branding.
In accordance with information from Benzinga Professional, Akerna Corp has a 52-week excessive of $4.76 and a 52-week low of $0.26.